SCORPION THERAPEUTICS
Scorpion Therapeutics was founded to broaden the reach and impact of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0. Scorpionโs experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology.
SCORPION THERAPEUTICS
Industry:
Biotechnology Health Care Life Science
Founded:
2020-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.scorpiontx.com
Total Employee:
51+
Status:
Active
Contact:
(212) 841-1015
Email Addresses:
[email protected]
Total Funding:
270 M USD
Technology used in webpage:
ReCAPTCHA Mimecast DocuSign SparkPost
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
![]()
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
![]()
Current Employees Featured

![]()

![]()

Founder

![]()


Investors List
![]()
Boxer Capital
Boxer Capital investment in Series B - Scorpion Therapeutics
Surveyor Capital
Surveyor Capital investment in Series B - Scorpion Therapeutics
Casdin Capital
Casdin Capital investment in Series B - Scorpion Therapeutics
![]()
OrbiMed
OrbiMed investment in Series B - Scorpion Therapeutics
Vida Ventures
Vida Ventures investment in Series B - Scorpion Therapeutics
Nextech Invest
Nextech Invest investment in Series B - Scorpion Therapeutics
Omega Funds
Omega Funds investment in Series B - Scorpion Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Scorpion Therapeutics
![]()
EcoR1 Capital
EcoR1 Capital investment in Series B - Scorpion Therapeutics
![]()
Invus
Invus investment in Series B - Scorpion Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-22 | Scorpion Therapeutics Announces Appointment of Brian Piper as Chief Financial Officer |
Official Site Inspections
http://www.scorpiontx.com Semrush global rank: 4.17 M Semrush visits lastest month: 2.84 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
